The clinical features and prognosis of chronic posthypoxic myoclonus

Movement Disorders

Volumn 12, Issue 2, 1997, Pages 216-220

  Werhahn, K J ^a,c   Brown, P ^a,b   Thompson, P D ^a,d   Marsden, C D ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Adams syndrome; Lance; Myoclonus; Postanoxia

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; PHENYTOIN; PIRACETAM; PRIMIDONE; VALPROIC ACID;

ADULT; AGED; ARTICLE; ASTHMA; BRAIN CORTEX; BRAIN STEM; CARDIOPULMONARY INSUFFICIENCY; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; DISABILITY; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HUMAN; HYPOXIA; MALE; MYOCLONUS; NEUROLOGIC DISEASE; NEUROPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; STARTLE REFLEX; WALKING;

ADULT; AGED; BRAIN DAMAGE, CHRONIC; CEREBRAL CORTEX; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOXIA, BRAIN; MALE; MIDDLE AGED; MYOCLONUS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS;

EID: 0030952258     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120212     Document Type: Article

References (14)

1. Lance JW, Adams RD. The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain 1963;86:111-136.
2. Fahn S. Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogen. Adv Neurol 1979;26:4984.
3. Thompson PD, Maertens de Noordhout A, Day BL, Rothwell JC, van der Kamp W, Marsden CD. Clinical and electrophysiological observations in post-anoxic myoclonus. In: Crossman AR, Sanbrook MA, eds. Neural mechanisms in disorders of movement. London: John Libbey, 1988:375-381.
4. Hallett M, Chadwick D, Adam J, Marsden CD. Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus. J Neurol Neurosurg Psychiatry 1977;40:253-254.
5. Fahn S. Posthypoxic action myoclonus: literature review update. Adv Neurol 1986;43:157-169.
6. De Lean J, Richardson JC, Rewcastle NB. Pathological findings in a case of hypoxic myoclonus treated with 5-hydroxytryptophan and a decarboxylase inhibitor. Adv Neurol 1986;43:215-223.
7. Brown P, Day BL, Rothwell JC, Thompson PD, Marsden CD. Intrahemispheric and interhemispheric spread of cerebral cortical myoclonic activity and its relevance to epilepsy. Brain 1991;114:2333-2351.
8. Brown P, Thompson PD, Rothwell JC, Britton TC, Day BL, Marsden CD. The hyperekplexias and their relationship to the normal startle reflex. Brain 1991;114:1903-1928.
9. Brown P, Thompson PD, Rothwell JC, Day BL, Marsden CD. A case of postanoxic encephalopathy with cortical action and brainstem reticular reflex myoclonus. Mov Disord 1991;6(2):139-144.
10. Marsden CD, Hallett M, Fahn S. The nosology and pathophysiology of myoclonus. In: Marsden CD, Fahn S, eds. Neurology 2 - movement disorders. London: Butterworth Scientific, 1981:196-248.
11. Obeso JA, Artieda J, Rothwell JC, et al. The treatment of severe action myoclonus. Brain 1988;112:765-777.
12. Brown P, Steiger MJ, Thompson PD, et al. Effectiveness of piracetam in cortical myoclonus. Mov Disord 1993;8:63-8.
13. Brown P. Myoclonus: a practical guide to drug therapy. CNS Drugs 1995;3:22-29.
14. Young RR, Shahani BT. Clinical neurophysiological aspects of post-hypoxic intention myoclonus. Adv Neurol 1979;26:85-105.